Skip to main content
. 2021 Jan 27;126(6):804–817. doi: 10.1007/s11547-020-01331-7

Table 1.

Clinical, Neuroimaging and Procedure Variables and Outcomes

Clinical variables Procedure variables
Age-years, mean (SD) General Anesthesia, n (%) 104 (45.8)
All 65.9 (12.9) Intracranial Thrombectomy, n (%)a
Plaque 70.6 (9.7) TA 108 (47.6)
Dissection 51.3 (10.7) SCoT 69 (30.4)
Male gender, n (%) 154 (67.8) eCAS, n (%) 132 (58.1)
Risk Factors, n (%) Order of Treatment, n (%)

Hypertension

Diabetes Mellitus

Dyslipidemia

Smoking Habit

137 (60.4)

36 (15.9)

55 (24.2)

75 (33.0)

Anterograde approach

Retrograde approach

67/132 (50.8)

65/132 (49.2)

Baseline NIHSS, median (IQR) Antiplatelet therapy, n (%)

All

General Anesthesia

Conscious Sedation

16.0 (11.0–20.0)

18.0 (13.8–21.3)

15.0 (10.0-18.0)

ASA

P2Y12 Inhibitors

GpIIb/IIIa Inhibitors

63 (27.8)

8 (3.5)

59 (26.0)

Timing-minutes, mean (SD)
IV-FL, n (%) 146 (64.3)

OTG

GTR

253.6 (118.4)

76.0 (43.3)

Neuroimaging variables Outcomes
Baseline ASPECTS, median (IQR) 90-day mRS ≤2, n (%)b

All

eCAS patients

with SICH

without SICH

9.0 (8.0–10.0)

8.0 (7.8–9.0)

9.0 (8.0–10.0)

All

No-SICH patients

with eCAS

without eCAS

100 (49.8)

63/96 (65.6)

37/83 (44.6)

Intracranial lesion site, n (%) mTICI 2b-3, n (%) 175 (77.1)

ICA

ICA T-type

M1-MCA

M2 or distal-MCA

Hemodynamic TLs

15 (6.6)

42 (18.5)

97 (42.7)

41 (18.1)

32 (14.1)

Extracranial ICA Recanalization, n (%)c 197 (86.8)
Complications, n (%)

All

TA

SCoT

38 (16.7)

17/108 (15.7)

21/69 (30.4)

Extracranial lesion SICH, n (%) 22 (9.7)
1. Etiology, n (%) 90-day mortality, n (%)d

Plaque

Dissection

172 (75.8)

55 (24.2)

All

Stroke-related

29 (14.4)

15 (7.5)

2. Type, n (%)

Occlusion

Subocclusion or Stenosis

130 (57.3)

97 (42.7)

Collateral Flow, n (%)

Good

Moderate

Poor

99 (43.6)

75 (33.0)

53 (23.4)

aThrombectomy not performed in 50 patients

b90-day mRS available for 201 patients

cExtracranial ICA recanalization obtained through percutaneous transluminal angioplasty without eCAS in 65 patients

d90-day mortality available for 201 patients

NIHSS National Institutes of Health Stroke Scale; ASPECTS Alberta Stroke Program Early CT Score; IV-FL Intravenous Fibrinolysis; eCAS emergent Carotid Artery Stenting; SICH Symptomatic Intracerebral Haemorrhage; ICA Internal Carotid Artery; MCA Middle Cerebral Artery; TLs Tandem Lesions; TA Thromboaspiration Alone; SCoT Stent-retriever Combined Thrombectomy; ASA Acetylsalicylic Acid; GpIIb/IIIa Glycoprotein IIb/IIIa OTG: Onset To Groin puncture; GTR Groin Puncture To Reperfusion.